LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases
返回论文页
Review article|更新时间:2022-11-09
|
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases
Genes & Diseases2022年9卷第6期
作者机构:
1. College of Medical Science, China Three Gorges University,Hubei,Yichang,PR China,443002
2. Third-Grade Pharmacological Laboratory on Chinese Medicine Approved by State Administration of Traditional Chinese Medicine, Medical College of China Three Gorges,Hubei,Yichang,PR China,443002
3. Hubei Key Laboratory of Tumour Microenvironment and Immunotherapy, China Three Gorges University,Hubei,Yichang,PR China,443002
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases[J]. Genes & Diseases, 2022,9(6).
Fangqi Xia, Yaqi Wang, Mengzhen Xue, et al. LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases[J]. Genes & Diseases, 2022,9(6).
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2021.07.003.
Fangqi Xia, Yaqi Wang, Mengzhen Xue, et al. LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2021.07.003.
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases
摘要
Abstract
Long non-coding RNAs (lncRNAs) exhibit a length more than 200 nucleotides and they are characterized by non-coding RNAs (ncRNA) not encoded into proteins. Over the past few years
the role and development of lncRNAs have aroused the rising attention of researchers. To be specific
KCNQ1OT1
the KCNQ1 opposite strand/antisense transcript 1
is clearly classified as a regulatory ncRNA. KCNQ1OT1 is capable of interacting with miRNAs
RNAs and proteins
thereby affecting gene expression and various cell functions (e.g.
cell proliferation
migration
epithelial–mesenchymal transition (EMT)
apoptosis
viability
autophagy and inflammation). KCNQ1OT1 is dysregulated in a wide range of human diseases (e.g.
cardiovascular disease
cancer
diabetes
osteoarthritis
osteoporosis and cataract)
and it is speculated to act as a therapeutic target for treating various human diseases. On the whole
this review aims to explore the biological functions
underlying mechanisms and pathogenic roles of KCNQ1OT1 in human diseases.